CompletedNCT00550706Updated Jun 11, 2013

Drug Utilization Prevalence in a Pediatric Care Medical Center

An observational study in Infectious Diseases, Metabolic Diseases and Cancer, sponsored by Rambam Health Care Campus. Completed at 1 site in Israel. Open to participants aged 1 Month to 18 Years. Per ClinicalTrials.gov, last updated 2013-06-11.

Sponsored by Rambam Health Care Campus · Observational

Study type: Observational
Model: Case-only
Time perspective: Prospective
Enrollment: 567
Ages: 1 Month to 18 Years
Sex: All

Study summary

One year prospective analysis of drug utilization and prescription point prevalence of medications in a pediatric tertiary care university medical center. Off-label use of medications in the study population will be also registered.

Conditions studied

Infectious Diseases
Metabolic Diseases
Cancer

Browse trials for

Keywords

Prescription point prevalence
Drug utilization
Define Daily Dose

In context

Communicable Diseases

4,452 studies on the registry are indexed under Communicable Diseases; 521 are open to participants now.

This study's enrollment of 567 is above the median of 244 across 1,499 observational studies indexed under Communicable Diseases.

Browse Communicable Diseases studies →

Lead sponsor

Rambam Health Care Campus is the lead sponsor of 456 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 1 Month to 18 Years
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Non-probability sample

Study population

Admitted children for medical treatment in two different pediatric departments

Inclusion criteria

All admitted children receiving at least one prescribed or OTC medication.

Exclusion criteria

Exclusion Criteria:

All admitted children who do not get a prescribed or OTC medication.

Study design

Observational model: Case-only
Time perspective: Prospective
Enrollment: 567 participants (actual)

Groups and cohorts

1Pediatric Dept A
Children's files from this department will be analysed once weekly and medication prescription data will be registered
2 Pediatric Dept B
Children's files from this department will be analysed once weekly and medication prescription data will be registered

What researchers measure

Primary outcomes

Descriptive use of medications
Time frame: One year

Study locations

1 site

Rambam Health Care Campus
Haifa, 31096, Israel

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Jun 11, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT00550706
Lead sponsor: Rambam Health Care Campus
Responsible party: Sponsor
First posted: Oct 30, 2007
Start date: Oct 2007
Primary completion: Apr 2008
Completion: Apr 2008
Last update: Jun 11, 2013

Study contacts

Norberto Krivoy, MD

principal investigator · Rambam Health Care Campus

Oversight

Data monitoring committee: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Communicable Diseases→

Other studies from this sponsor

Rambam Health Care Campus

Start the discussion